In NAFLD patients, both plasma DPP4 activity and concentration linearly correlated with hepatic inflammation and steatosis grade at the liver biopsy, and with clinical markers of hepatic damage. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatotic liver disease.